Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.19 Analyst target: $4.14 Upside: 2090.90%
Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of chronic pain. The company is headquartered in Boston, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.